Completed (8)

Recruiting (4)

Active, not recruiting (2)

Terminated (2)

Withdrawn (2)

Unknown status (1)

phase 2 (12)

phase 1 (4)

early phase 1 (1)

n/a (1)

phase 1/phase 2 (1)

M.D. Anderson Cancer Center (9)

National Cancer Institute (NCI) (7)

Burzynski Research Institute (1)

Morphotek (1)

Vanderbilt-Ingram Cancer Center (1)

National Cancer Institute (NCI) (8)

Children's Oncology Group (1)

Ziopharm Oncology (1)

drug (15)

other (10)

biological (7)

procedure (2)

Other (11)

NIH (7)

Industry (1)

Interventional (19)

recurrent mantle cell lymphoma

Showing NaN - NaN of 19

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS